BioSpace News Archive

International medical imaging IT and cybersecurity company Sectra helps customers provide patients with the best possible care and protect society’s critical infrastructure and communication where it is the most vulnerable.

Transparency Market Research has published a new report on the systemic inflammatory response syndrome treatment market.

Organs-on-chips or organ-on-a-chip is an electronic gadget that consists of a 3D microfluidic cell culture-based multi-channel structure.

Transparency Market Research has published a new report on the global controlled substance Market for the forecast period of 2019 - 2027.

The branch of science that deals with manufacturing medicines and pharmaceutical products based on biological origins is called biological therapeutics.

ImmVira will present results from its clinical Phase I study of MVR-T3011 via intratumoral administration at the 2021 American Society of Clinical Oncology Annual Meeting on June 4-8, 2021 for the first time.

ViaDerma, Inc., is pleased to announce they have expanded their current licensing agreement with a home health wound care network.

BD, a leading global medical technology company, announced that it has become the first medical technology company authorized as a Common Vulnerability and Exposures Numbering Authority by the CVE Program, further demonstrating the company’s leadership in health care cybersecurity.

Highly experienced executive to lead clinical development as Avisa prepares pivotal trials for Avisa BreathTest™ for post-COVID-19 long haul and ventilator-associated pneumonia patients

TELA Bio, Inc., a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstruction, announced that it has appointed John Nosenzo, the Chief Commercial Officer of Bioventus Inc., to its board of directors effective June 2, 2021.